Application of
next generation sequencing (NGS) is revolutionizing the clinical molecular
diagnostics industry. As this occurs, guidelines
for validating NGS processes are limited, non-specific, and rapidly
evolving.
NGS validation
projects are complex and expensive, so the validation experiments must be
carefully considered, while being certain all current and evolving regulatory
requirements are met.
We validated an
end-to-end genetic testing process for a 16-gene hereditary colorectal cancer
NGS panel. Global work flow was designed to provide high quality sequencing
data for 100% of our targeted regions.
No comments:
Post a Comment